Visual analysis of allergic rhinitis in children based on web of science and CiteSpace software

Fang Liu1, Na Chen1, Rui Wang1

  • 1Department of Otolaryngology, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.

Frontiers in Pediatrics
|October 17, 2022
PubMed

Insights

Research on allergic rhinitis (AR) in children is growing. Bibliometric analysis reveals key research areas including pathogenesis, comorbidity, epidemiology, symptoms, and therapy, with immunotherapy and severity as emerging trends.

Area of Science:

  • Pediatrics
  • Immunology
  • Bibliometrics

Background:

  • Allergic Rhinitis (AR) in children is a growing public health concern.
  • Limited bibliometric studies exist on pediatric AR research trends.

Purpose of the Study:

  • To explore research hotspots and emerging trends in pediatric Allergic Rhinitis.
  • To conduct a bibliometric analysis of publications on AR in children.

Main Methods:

  • Searched Web of Science (WOS) Core Collection for relevant publications up to December 31, 2021.
  • Utilized CiteSpace and Microsoft Excel for visualized bibliometric analysis.
  • Included 649 articles in the final analysis.

Main Results:

  • A steady increase in pediatric AR publications over the past 20 years.
  • China and the USA lead in research output; Giorgio Ciprandi is the most prolific author.
  • Key research areas identified include pathogenesis, comorbidity, epidemiology, symptoms, and therapy of AR in children.

Conclusions:

  • Pediatric AR research has shown gradual improvement over two decades.
  • Pathogenesis, comorbidity, epidemiology, symptoms, and therapy are current research hotspots.
  • Immunotherapy and disease severity are identified as probable future research directions.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
28.2K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
936
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
404